PRIMUS MODEL CLC 330

Assay, Glycosylated Hemoglobin

PRIMUS, INC.

The following data is part of a premarket notification filed by Primus, Inc. with the FDA for Primus Model Clc 330.

Pre-market Notification Details

Device IDK891235
510k NumberK891235
Device Name:PRIMUS MODEL CLC 330
ClassificationAssay, Glycosylated Hemoglobin
Applicant PRIMUS, INC. 4747 TROOST Kansas City,  MO  64110
ContactJanet Svoboda
CorrespondentJanet Svoboda
PRIMUS, INC. 4747 TROOST Kansas City,  MO  64110
Product CodeLCP  
CFR Regulation Number864.7470 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-03-07
Decision Date1989-06-16

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516748636 K891235 000
05391516744164 K891235 000
05391516744171 K891235 000
05391516744218 K891235 000
05391516744270 K891235 000
05391516744287 K891235 000
05391516744294 K891235 000
05391516744317 K891235 000
05391516744546 K891235 000
05391516744553 K891235 000
05391516748155 K891235 000
05391516748162 K891235 000
05391516748605 K891235 000
05391516748612 K891235 000
05391516748629 K891235 000
05391516744126 K891235 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.